{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:10:11Z","timestamp":1761419411862,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rgmx.2020.06.001","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T04:10:44Z","timestamp":1592367044000},"page":"312-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Manejo farmacol\u00f3gico de pacientes con enfermedades hep\u00e1ticas y pancre\u00e1ticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVID-19)"],"prefix":"10.1016","volume":"85","author":[{"given":"G.","family":"Miranda-Zazueta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gonz\u00e1lez-Regueiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Garc\u00eda-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Moctezuma-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"L\u00f3pez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"P\u00e9rez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.F.","family":"Uscanga-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pel\u00e1ez-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2020.06.001_bib0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.05.013","article-title":"High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry","author":"Moon","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0160","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: Autoimmune hepatitis","volume":"63","author":"Lohse","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0170","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.jhepr.2020.100113","article-title":"Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0175","unstructured":"COVID-19: Guidance for rheumatologists. British Society for Rheumatology. 2020. Disponible en: https:\/\/www.rheumatology.org.uk\/news-policy\/details\/covid19-coronavirus-update-members"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0180","unstructured":"Coronavirus facts for chronic illness patients who are immune-compromised. Disponible en: https:\/\/creakyjoints.org\/living-with-arthritis\/coronavirus-facts-for-chronic-illness-patients\/"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0185","unstructured":"European League Against Rheumatism. EULAR Guidance for patients COVID-19 outbreak. 2020. Disponible en: https:\/\/www.eular.org\/eular_guidance_for_patients_covid19_outbreak.cfm"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0190","unstructured":"COVID-19 Drug Interactions. University of Liverpool. 2020. Disponible en: https:\/\/www.covid19-druginteractions.org\/"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0195","unstructured":"FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. FDA. 2020. Disponible en: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0205","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0210","article-title":"Coronavirus disease 2019 and transplantation: A view from the inside","author":"Andrea","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15890","article-title":"Novel coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve","author":"Fishman","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0220","article-title":"Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus2 infection in transplant recipients","author":"Ju","year":"2020","journal-title":"Chronic Dis Transl Med."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0225","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S2468-1253(20)30116-3","article-title":"COVID-19 in long-term liver transplant patients: Preliminary experience from an Italian transplant centre in Lombardy","volume":"5","author":"Bhoori","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0230","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: Management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0235","unstructured":"Clinical insights for hepatology and liver transplant providers during the COVID-19 pandemic. AASLD. 2020. Disponible en: https:\/\/www.aasld.org\/about-aasld\/covid-19-and-liver"},{"key":"10.1016\/j.rgmx.2020.06.001_bib0240","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: The facts during the third epidemic","volume":"26","author":"D\u2019Antiga","year":"2020","journal-title":"Liver Transpl."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0245","article-title":"Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy","volume":"25","author":"Norsa","year":"2020","journal-title":"Gastroenterology."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0250","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0255","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","article-title":"International consensus for the treatment of autoimmune pancreatitis","volume":"17","author":"Okazaki","year":"2017","journal-title":"Pancreatology."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0673-8","article-title":"Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: A systematic review and network meta-analysis","volume":"14","author":"Singh","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0280","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00296-019-04272-1","article-title":"Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases","volume":"39","author":"Vikse","year":"2019","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0285","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/2050640619862459","article-title":"Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective","volume":"7","author":"Soliman","year":"2019","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.rgmx.2020.06.001_bib0290","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open."}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090620300653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:46:52Z","timestamp":1759812412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090620300653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0375090620300653"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2020.06.001","relation":{},"ISSN":["0375-0906"],"issn-type":[{"type":"print","value":"0375-0906"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manejo farmacol\u00f3gico de pacientes con enfermedades hep\u00e1ticas y pancre\u00e1ticas que involucran terapias inmunosupresoras. Posicionamiento en el marco de la pandemia de SARS-CoV-2 (COVID-19)","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2020.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}